Literature DB >> 16997052

Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy.

Uta Erdbruegger1, Alexander Woywodt, Torsten Kirsch, Hermann Haller, Marion Haubitz.   

Abstract

BACKGROUND: Circulating endothelial cells (CECs) are a reliable marker of disease activity in a variety of vascular disorders. Damage to microvascular endothelial cells is a hallmark of thrombotic microangiopathy (TMA). The aim of this study is to identify and count CECs during the course of TMA and evaluate whether cell numbers may serve as a prognostic marker in patients undergoing plasma exchange.
METHODS: Fifteen patients (8 women, 7 men) aged 31 to 66 years with TMA of different causes were studied before and after 4 sessions of plasma exchange. CECs were isolated by using anti-CD146-driven immunomagnetic isolation and counted after staining with Ulex Europaeus lectin-1.
RESULTS: Numbers of CECs were markedly elevated in all patients before treatment (64 to 672 CEC/mL; mean, 320 +/- 205 CEC/mL) compared with healthy controls (0 to 16 CEC/mL; mean, 6.4 +/- 4.2 CEC/mL; P < 0.001). Patients with a favorable outcome had significantly greater initial CEC levels (mean, 426 +/- 175 CEC/mL; P < 0.001), and cell numbers decreased significantly after 4 treatments of plasma exchange (mean, 101 +/- 53 CEC/mL; P = 0.001). Patients with disease unresponsive to plasma exchange presented with lower initial CEC levels (mean, 108 +/- 36 CEC/mL), and numbers failed to decrease after plasma exchange (mean, 114 +/- 57 CEC/mL; P = 0.827).
CONCLUSION: Markedly elevated numbers of CECs reflect severe and widespread endothelial damage in patients with TMA. Cell numbers at presentation and their degree of decrease after 4 sessions of plasma exchange could provide important prognostic clues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997052     DOI: 10.1053/j.ajkd.2006.06.013

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?

Authors:  Sonata Jodele; Benjamin L Laskin; Jens Goebel; Jane C Khoury; Susan L Pinkard; Patricia M Carey; Stella M Davies
Journal:  Transfusion       Date:  2012-07-15       Impact factor: 3.157

Review 2.  Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.

Authors:  J Khosla; A C Yeh; T R Spitzer; B R Dey
Journal:  Bone Marrow Transplant       Date:  2017-10-02       Impact factor: 5.483

3.  Severe endothelial injury and subsequent repair in patients after successful cardiopulmonary resuscitation.

Authors:  Katrin Fink; Meike Schwarz; Linda Feldbrügge; Julia N Sunkomat; Tilmann Schwab; Natascha Bourgeois; Manfred Olschewski; Constantin von Zur Mühlen; Christoph Bode; Hans-Jörg Busch
Journal:  Crit Care       Date:  2010-06-04       Impact factor: 9.097

4.  tHe USual Suspects.

Authors:  Peter Maginnis; John Anderton; Beena Nair; Alexander Woywodt
Journal:  NDT Plus       Date:  2011-03-31

5.  Enumeration of circulating endothelial cell frequency as a diagnostic marker in aortic valve surgery - a flow cytometric approach.

Authors:  Anton Sabashnikov; Klaus Neef; Vera Chesnokova; Leonie Wegener; Kathrin Godthardt; Maximilian Scherner; Elmar W Kuhn; Antje-Christin Deppe; Meike Lauer; Kaveh Eghbalzadeh; Mohamed Zeriouh; Parwis B Rahmanian; Jens Wippermann; Ferdinand Kuhn-Régnier; Navid Madershahian; Thorsten Wahlers; Alexander Weymann; Yeong-Hoon Choi
Journal:  J Cardiothorac Surg       Date:  2017-08-09       Impact factor: 1.637

Review 6.  Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence.

Authors:  F Sabatier; L Camoin-Jau; F Anfosso; J Sampol; F Dignat-George
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

Review 7.  Circulating endothelial cells and chronic kidney disease.

Authors:  Kunying Zhang; Fang Yin; Lin Lin
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.